299 related articles for article (PubMed ID: 25941221)
1. Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides.
Mojsoska B; Zuckermann RN; Jenssen H
Antimicrob Agents Chemother; 2015 Jul; 59(7):4112-20. PubMed ID: 25941221
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial mechanisms of GN-2 derived peptides and peptoids against Escherichia coli.
Saporito P; Biljana M; Løbner Olesen A; Jenssen H
Biopolymers; 2019 Jun; 110(6):e23275. PubMed ID: 30951211
[TBL] [Abstract][Full Text] [Related]
3. Effect of side chain hydrophobicity and cationic charge on antimicrobial activity and cytotoxicity of helical peptoids.
Lee J; Kang D; Choi J; Huang W; Wadman M; Barron AE; Seo J
Bioorg Med Chem Lett; 2018 Jan; 28(2):170-173. PubMed ID: 29198866
[TBL] [Abstract][Full Text] [Related]
4. Lysine-Based α-Peptide/β-Peptoid Peptidomimetics: Influence of Hydrophobicity, Fluorination, and Distribution of Cationic Charge on Antimicrobial Activity and Cytotoxicity.
Molchanova N; Hansen PR; Damborg P; Nielsen HM; Franzyk H
ChemMedChem; 2017 Feb; 12(4):312-318. PubMed ID: 28052595
[TBL] [Abstract][Full Text] [Related]
5. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
[TBL] [Abstract][Full Text] [Related]
6. High in vitro antimicrobial activity of β-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis.
Liu Y; Knapp KM; Yang L; Molin S; Franzyk H; Folkesson A
Int J Antimicrob Agents; 2013 Jan; 41(1):20-7. PubMed ID: 23153961
[TBL] [Abstract][Full Text] [Related]
7. Dimeric peptoids as antibacterial agents.
Bahatheg G; Kuppusamy R; Yasir M; Bridge S; Mishra SK; Cranfield CG; StC Black D; Willcox M; Kumar N
Bioorg Chem; 2024 Jun; 147():107334. PubMed ID: 38583251
[TBL] [Abstract][Full Text] [Related]
8. Alternating Cationic-Hydrophobic Peptide/Peptoid Hybrids: Influence of Hydrophobicity on Antibacterial Activity and Cell Selectivity.
Frederiksen N; Hansen PR; Zabicka D; Tomczak M; Urbas M; Domraceva I; Björkling F; Franzyk H
ChemMedChem; 2020 Dec; 15(24):2544-2561. PubMed ID: 33029927
[TBL] [Abstract][Full Text] [Related]
9. A comparison of linear and cyclic peptoid oligomers as potent antimicrobial agents.
Huang ML; Shin SB; Benson MA; Torres VJ; Kirshenbaum K
ChemMedChem; 2012 Jan; 7(1):114-22. PubMed ID: 21990117
[TBL] [Abstract][Full Text] [Related]
10. Novel lysine-peptoid hybrids with antibacterial properties.
Ryge TS; Hansen PR
J Pept Sci; 2005 Nov; 11(11):727-34. PubMed ID: 16161020
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials.
Green RM; Bicker KL
Int J Antimicrob Agents; 2020 Aug; 56(2):106048. PubMed ID: 32540430
[TBL] [Abstract][Full Text] [Related]
12. Peptoids successfully inhibit the growth of gram negative E. coli causing substantial membrane damage.
Mojsoska B; Carretero G; Larsen S; Mateiu RV; Jenssen H
Sci Rep; 2017 Feb; 7():42332. PubMed ID: 28195195
[TBL] [Abstract][Full Text] [Related]
13. Halogenation as a tool to tune antimicrobial activity of peptoids.
Molchanova N; Nielsen JE; Sørensen KB; Prabhala BK; Hansen PR; Lund R; Barron AE; Jenssen H
Sci Rep; 2020 Sep; 10(1):14805. PubMed ID: 32908179
[TBL] [Abstract][Full Text] [Related]
14. Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation.
Gobbo M; Benincasa M; Bertoloni G; Biondi B; Dosselli R; Papini E; Reddi E; Rocchi R; Tavano R; Gennaro R
J Med Chem; 2009 Aug; 52(16):5197-206. PubMed ID: 20560644
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial beta-peptoids by a block synthesis approach.
Shuey SW; Delaney WJ; Shah MC; Scialdone MA
Bioorg Med Chem Lett; 2006 Mar; 16(5):1245-8. PubMed ID: 16384703
[TBL] [Abstract][Full Text] [Related]
16. In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents.
Czyzewski AM; Jenssen H; Fjell CD; Waldbrook M; Chongsiriwatana NP; Yuen E; Hancock RE; Barron AE
PLoS One; 2016; 11(2):e0135961. PubMed ID: 26849681
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial discovery process yields antimicrobial peptoids.
Ng S; Goodson B; Ehrhardt A; Moos WH; Siani M; Winter J
Bioorg Med Chem; 1999 Sep; 7(9):1781-5. PubMed ID: 10530925
[TBL] [Abstract][Full Text] [Related]
18. Novel tetrameric cell penetrating antimicrobial peptoids effective against mycobacteria and drug-resistant
Fleck BS; Mukherjee D; Tram NDT; Ee PLR; Schepers U
Front Biosci (Landmark Ed); 2022 Feb; 27(2):64. PubMed ID: 35227007
[TBL] [Abstract][Full Text] [Related]
19. Real-Time Monitoring of Multitarget Antimicrobial Mechanisms of Peptoids Using Label-Free Imaging with Optical Diffraction Tomography.
Kim M; Cheon Y; Shin D; Choi J; Nielsen JE; Jeong MS; Nam HY; Kim SH; Lund R; Jenssen H; Barron AE; Lee S; Seo J
Adv Sci (Weinh); 2023 Aug; 10(24):e2302483. PubMed ID: 37341246
[TBL] [Abstract][Full Text] [Related]
20. Substitution of the GalNAc-α-O-Thr¹¹ residue in drosocin with O-linked glyco-peptoid residue: effect on antibacterial activity and conformational change.
Ahn M; Murugan RN; Nan YH; Cheong C; Sohn H; Kim EH; Hwang E; Ryu EK; Kang SW; Shin SY; Bang JK
Bioorg Med Chem Lett; 2011 Oct; 21(20):6148-53. PubMed ID: 21890357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
